Micropep Technologies has appointed Kim White as chief program officer and member of the company’s executive committee.
Micropep Technologies is a French American ag tech company developing a new generation of targeted, sustainable crop protection products using micropeptides. Through its proprietary discovery platform Krisalix, Micropep says it designs short protein molecules that precisely regulate plant gene expression and is currently developing its first product, a biofungicide with a novel mode of action targeting major fungal diseases.
White’s track record spans global operations, R&D, analytics and cross-functional program leadership. Prior to joining Micropep, she held senior leadership roles at Invaio Sciences and Syngenta, where she focused on operational strategy, data-driven enablement and the delivery of complex, multistakeholder programs.
In her new role, White will oversee Micropep’s global program portfolio, driving strategic alignment and operational excellence as the company advances from research to commercialization. She will lead the planning and coordination of internal initiatives and strengthen the company’s integrated research-to-commercial operating model.
In addition, as scientific key account lead, she will serve as the primary interface with external partners, overseeing the execution of revenue-generating joint research partnerships enabled by Micropep’s Krisalix discovery platform and embedding partner needs directly into program delivery, the company says.
“Kim’s appointment marks a pivotal milestone as Micropep transitions from pure research into a commercialization phase,” says Georg Goeres, CEO of Micropep Technologies. “Driving a project-based and customer-focused mindset across the organization is essential to scaling our innovations and delivering value to growers and partners. Kim’s leadership will ensure every program is aligned, prioritized and executed with the rigor required to bring our micropeptide solutions to market.”
